Corcept Therapeutics Pre-Tax Income 2010-2024 | CORT

Corcept Therapeutics pre-tax income for the twelve months ending September 30, 2024 was $0.166B, a 48.48% increase year-over-year.

  • Corcept Therapeutics annual pre-tax income for 2023 was $0.125B, a 7.2% increase from 2022.
  • Corcept Therapeutics annual pre-tax income for 2022 was $0.116B, a 7.05% decline from 2021.
  • Corcept Therapeutics annual pre-tax income for 2021 was $0.125B, a 5.01% decline from 2020.

Corcept Therapeutics Pre-Tax Income 2010-2024 | CORT

  • Corcept Therapeutics annual pre-tax income for 2023 was $0.125B, a 7.2% increase from 2022.
  • Corcept Therapeutics annual pre-tax income for 2022 was $0.116B, a 7.05% decline from 2021.
  • Corcept Therapeutics annual pre-tax income for 2021 was $0.125B, a 5.01% decline from 2020.